Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Pavithra Gowda

Physician Assistant Germantown, MD Physician Assistant

NPI 1174073332 CMS profile 11163985

19735 Germantown Rd Ste 360, Germantown, MD 20874

Open in the dashboard

General payments

$2,675

131 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pavithra Gowda of Germantown, MD is reported in the CMS Open Payments database as having received $2,675 across 131 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $152 2
2024 General $17 1
2023 General $29 2
2022 General $1,053 49
2021 General $1,423 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pavithra Gowda
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Pavithra Gowda were reported at $152. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Pavithra Gowda Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,423 $132 $37–$438 $132
2022 $1,053 $155 $48–$522 $149
2023 $29 $167 $52–$557 $160
2024 $17 $178 $55–$600 $164
2025 $152 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $386 15 payments
  2. Abbott Laboratories $350 9 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $324 30 payments
  4. Pacira Pharmaceuticals Incorporated $238 2 payments
  5. Collegium Pharmaceutical, Inc. $212 13 payments
  6. Biohaven Pharmaceutical Holding Company Ltd. $185 7 payments
  7. AbbVie, Inc. $178 4 payments
  8. Biohaven Pharmaceuticals, Inc. $172 8 payments
  9. Medtronic, Inc. $138 5 payments
  10. Medical Device Business Services, Inc. $137 1 payment
  11. Other $356 37 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,515 111 payments
  2. Education $160 20 payments
Products named General payments · program years 2021–2025
  1. NURTEC ODT $357 15 payments
  2. RELISTOR Gastroenterology $324 30 payments
  3. RELISTOR Gastroenterology $324 30 payments
  4. Exparel $238 2 payments
  5. PROCLAIM $206 6 payments
  6. WaveWriter Alpha Prime 16 $204 7 payments
  7. XTAMPZA $198 12 payments
  8. UBRELVY $149 3 payments
  9. SPECTRA WAVEWRITER $149 6 payments
  10. Proclaim IPG $143 3 payments
  11. Other $774 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Physician Assistant: 241

Drug cost

$166

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 17 $166

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$2,341

Of which drugs: $494

Medicare patients

29

Average age 73

Services billed

293

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 52%
Diabetes 41%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 19 190 $123

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record